Definitive Contract 75N91021C00002
Award Date
12/11/20
Potential Completion Date
12/10/21
Potential Value
$4.1M
Federal Agency
National Cancer Institute
Awardee
Healthverity Inc.
Ultimate Awardee
Not listed
NAICS Category
518210 - Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
PSC Category
AJ14 - General Science And Technology R&D Services; General Science And Technology; R&D Administrative Expenses
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
MIDDLE CITY WEST, PA 19103, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) awarded a $2,289,704.96 Firm Fixed Price Purchase Order contract to Healthverity Inc., a for-profit data analytics company, to provide data variables and analysis services supporting the Advanced Research Projects Agency for Health (ARPA-H) Resilient Systems Office's Market Overhaul to Reward Public Health Elevation in the United States (MORPHEUS) program. The contract, which has no set-aside designation, requires Healthverity to deliver privacy-preserving...
This is a $14,860,700 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Healthverity Inc., a for-profit data analytics company. The contract is for data gathering and reporting services, specifically related to the COVID-19 pandemic response. Healthverity has previously provided the CDC and Department of Health and Human Services (HHS) with privacy-preserving record linkage (PPRL) software as a service to support over 325 million...
The Centers for Disease Control and Prevention awarded a $5.6 million definitive contract to Healthverity Inc. to implement privacy preserving record linkage within the COVID-19 immunization infrastructure. The one year firm fixed price contract will provide for implementation of privacy preserving record linkage technologies within the COVID-19 immunization infrastructure to support nationwide immunization monitoring efforts. Performance will take place in Middle City West, Pennsylvania over...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
The U.S. National Cancer Institute (NCI) awarded a Delivery Order worth $11,920,234.00 to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the ARPA-H BIOMEDICAL DATA FABRIC TOOLBOX PROGRAM, with an ultimate completion date of December 31, 2027. This award is part of Leidos Biomedical Research Inc.'s single-award Indefinite Delivery Contract with the NCI, valued at up to $6.6 billion over 5 years. The contract is a Cost Plus Fixed Fee arrangement and does...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (HHS-NIH-NIDA) awarded a $5 million firm fixed price delivery order contract to Palantir Technologies Inc. to provide N3C TASK services in support of the Coronavirus COVID-19 National Interest Action. The place of performance will be Denver, Colorado for the period of February 21, 2022 through May 24, 2022. No subcontractors or additional context about the products and services were...
The Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center awarded a $101,599.04 firm fixed-price purchase order to Revvity Health Sciences, Inc. to provide COVID-19 related equipment and reagents. The award has a Coronavirus COVID-19 National Interest Action Code and was completed on April 10, 2020, shortly after the initial contract award on April 6, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract has a ceiling value of $37,520,022 and a period of performance through August 30, 2024. The contract does not have a set-aside designation. Leidos Biomedical Research Inc. is an FFRDC (Federally Funded Research and...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Public Affairs to Prom Health Development, a non-profit organization and community development corporation. The contract, valued at $249,810.00, is for operational support related to the SARS-CoV-2 virus and COVID-19 for the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The scope of work includes...
This federal contract award, with an ID of 75N91019D00024|75N91020F00014, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract supports NIAID's goal to better understand the coronavirus, with an initial focus on the ACTIV3 clinical trial. The task order will initiate the management, oversight, and conduct of the NIAID DCR...